Treatment of herpes zoster with interferon alpha-2a

International Journal of Dermatology

Volumn 35, Issue 10, 1996, Pages 749-750

  Naoum, Christos ^a,b   Perissios, Andreas ^a   Varnavas, Vakis ^a   Lagos, Dimitrios ^a  

^a KAT HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HERPES ZOSTER; HUMAN; INFLUENZA; INTRADERMAL DRUG ADMINISTRATION; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; POSTHERPETIC NEURALGIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029856389     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb00658.x     Document Type: Article

References (10)

1. Fattovich B, Brollo L, Boscaro S, et al. Long-term effect of low-dose recombinant Interferon therapy in patients with chronic hepatitis B. Br J Hepatol 1989; 9:331-337.
2. Maddin ST. Current dermatologic therapy. Philadelphia: WB Saunders, 1991.
3. Engst R. Recombinant human leucocyte α-interferon within the therapy of herpes genitalis recidivans. Eur J Sex Transm Dis 1986; 3:69.
4. Baron S, Dianzani F, Stanton CD, Fleishmann WR, eds. The interferon system: a current review to 1987. Austin: University of Texas Press, 1987.
5. Isaaks A, Lindenmann J. Virus interference. The interferon. Proc R Soc Ser B 1957; 147:258-267.
6. Baron S, Tyring S, Fleishmann WR, et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266:1375-1383.
7. Arcese W, Mauro FR, Alimena B. Interferon therapy for Ph (1)-positive CML patients relapsing after T-cell depleted allogenic bone marrow transplantation. Bone Marrow Transpl 1990; 5:309-315.
8. Baron S. Mechanism of recovery from viral infection. In: Smith DM, Louffer MA, eds. Advances in virus research. New York, NY: Academic Press, 1963:39-60.
9. Rapp F, Wrzos H. Synergistic effect of human leucocyte interferon and nonoxynol 9 against herpes simplex virus type 2. Antimicrob Agents Chemother 1985; 28: 449-451.
10. Friedman-Kien A, Eron L, Conant M, et al. Natural interferon-α for treatment of condylomata acuminata. JAMA 1988; 259:4.